◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › S › SGRY

Surgery Partners Inc (SGRY) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL CARE FACILITIES · DATA UPDATED 2026-09-13

Surgery Partners Inc (SGRY) operates in the MEDICAL CARE FACILITIES industry and is headquartered in Brentwood, United States with about 16,000 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, SGRY reported $3.3B in revenue and ($78M) in net income.

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States.

Interactive charts & full statements → Open the SGRY valuation workbench →

SGRY Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31
Total Revenue	$3.4B	$3.3B	$3.1B	$2.7B	$2.5B	$2.2B	$1.9B	$1.8B	$1.8B	$1.3B	$1.1B	$960M	$403M	$285M	$260M
Gross Profit	$719M	$765M	$746M	$648M	$575M	$491M	$380M	$424M	$410M	$327M	$324M	$291M	$149M	$115M	$101M
Gross Margin %	21.4%	23.1%	23.9%	23.6%	22.6%	22.1%	20.4%	23.1%	23.2%	24.4%	28.3%	30.3%	37.0%	40.3%	38.8%
Operating Income (EBIT)	$400M	$390M	$349M	$328M	$345M	$302M	$183M	$236M	$78M	$158M	$196M	$145M	$51M	$58M	$60M
Operating Margin %	11.9%	11.8%	11.2%	12.0%	13.6%	13.6%	9.8%	12.9%	4.4%	11.8%	17.2%	15.1%	12.6%	20.5%	23.2%
Net Income	($89M)	($78M)	($168M)	($12M)	($55M)	($71M)	($116M)	($75M)	($206M)	($53M)	$9M	$1M	($66M)	($9M)	$2M
Net Margin %	-2.6%	-2.4%	-5.4%	-0.4%	-2.1%	-3.2%	-6.2%	-4.1%	-11.6%	-4.0%	0.8%	0.1%	-16.3%	-3.2%	0.7%
EBITDA	$948M	$566M	$501M	$446M	$460M	$401M	$278M	$310M	$145M	$252M	$245M	$59M	$66M	$70M	$72M
Earnings Per Share (EPS)	$-0.69	$-0.61	$-1.33	$-0.09	$-0.59	$-0.98	$-2.38	$-1.55	$-4.28	$-1.08	$0.20	$0.04	$-1.37	$-0.19	$0.04
Shares Outstanding (M)	129M	127M	126M	126M	92M	72M	49M	48M	48M	49M	48M	37M	48M	48M	48M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SGRY Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$849M	$811M	$885M	$822M	$826M	$776M	$864M	$770M
Gross Profit	$190M	$122M	$212M	$195M	$196M	$162M	$234M	$178M
Gross Margin %	22.4%	15.0%	24.0%	23.8%	23.7%	20.9%	27.0%	23.0%
Operating Income (EBIT)	$102M	$82M	$110M	$106M	$112M	$62M	$127M	$61M
Operating Margin %	12.0%	10.2%	12.4%	12.9%	13.5%	8.0%	14.7%	7.9%
Net Income	($15M)	($36M)	($15M)	($23M)	($2M)	($38M)	($108M)	($32M)
Net Margin %	-1.8%	-4.4%	-1.7%	-2.8%	-0.3%	-4.9%	-12.6%	-4.1%
EBITDA	$141M	$106M	$295M	$405M	$152M	$98M	$161M	$111M
Earnings Per Share (EPS)	$-0.12	$-0.28	$-0.12	$-0.18	$-0.02	$-0.30	$-0.86	$-0.25
Shares Outstanding (M)	129M	128M	127M	127M	127M	127M	126M	126M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SGRY Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31
Cash from Operations (CFO)	$258M	$274M	$300M	$294M	$159M	$87M	$247M	$130M	$145M	$121M	$125M	$84M	$22M	$49M	$46M
Capital Expenditures (CapEx)	$70M	$79M	$90M	$89M	$81M	$58M	$43M	$74M	$40M	$30M	$39M	$33M	$9M	$4M	$5M
Free Cash Flow (FCF)	$188M	$196M	$210M	$205M	$78M	$30M	$204M	$56M	$105M	$91M	$86M	$51M	$13M	$45M	$42M
FCF Margin %	5.6%	5.9%	6.7%	7.5%	3.1%	1.3%	11.0%	3.0%	5.9%	6.8%	7.5%	5.3%	3.1%	15.8%	16.0%
Dividends Paid	—	—	—	$0M	$147M	$5M	$110M	$121M	$8M	$1M	$86M	$1M	$93M	$131M	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SGRY Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$59M	$12M	$103M	$84M	$81M	$6M	$111M	$65M
Capital Expenditures (CapEx)	$22M	$16M	$13M	$20M	$23M	$23M	$22M	$20M
Free Cash Flow (FCF)	$38M	($4M)	$91M	$64M	$58M	($17M)	$89M	$45M
FCF Margin %	4.4%	-0.5%	10.2%	7.8%	7.0%	-2.1%	10.3%	5.8%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SGRY Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31
Total Assets	$8.1B	$8.2B	$7.9B	$6.9B	$6.7B	$6.1B	$5.4B	$5.0B	$4.7B	$4.6B	$2.3B	$2.1B	$1.9B	$475M
Cash & Cash Equivalents	$217M	$240M	$270M	$196M	$283M	$390M	$318M	$93M	$184M	$175M	$70M	$58M	$75M	$13M
Total Liabilities	$4.9B	$4.7B	$4.3B	$3.5B	$3.4B	$3.8B	$3.8B	$3.3B	$4.7B	$4.6B	$2.3B	$2.1B	$1.6B	$489M
Total Debt (Short + Long-Term)	$3.8B	$3.7B	$3.4B	$2.8B	$2.7B	$3.0B	$2.9B	$2.6B	$2.3B	$2.2B	$1.4B	$1.3B	$1.4B	$427M
Total Shareholders' Equity	$1.7B	$1.7B	$1.8B	$2.0B	$2.0B	$1.1B	$550M	$692M	$405M	$655M	$10M	($4M)	($264M)	($104M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SGRY viewer.

Other Companies in MEDICAL CARE FACILITIES

ACHC · Acadia Healthcare Company Inc — $3 billion
ADUS · Addus HomeCare Corporation — $2 billion
MD · Mednax Inc — $2 billion
SNDA · Sonida Senior Living Inc — $2 billion
ASTH · Astrana Health Inc — $2 billion
PIII · P3 Health Partners Inc — $2 billion
AGL · agilon health Inc — $1 billion
INNV · InnovAge Holding Corp — $1 billion

← SGRX All “S” companies SGSN →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.